Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

480.09
Delayed Data
As of Apr 24
 +0.01 / +0.00%
Today’s Change
269.50
Today|||52-Week Range
495.50
+17.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues625.7M665.7M725.8M802.3M
 
 
 
 
 
Cost of Goods Sold43.6M46.4M55.6M59.5M
 
 
 
 
 
Depreciation And Amortization11.5M13.0M14.0M14.1M
 
 
 
 
 
 
Operating ExpensesGross Income570.6M606.3M656.2M728.7M
 
 
 
 
 
General Expenses384.7M383.9M473.5M481.4M
 
 
 
 
 
Research And Development275.8M281.5M323.7M337.6M
 
 
 
 
 
Total Operating Expenses439.8M443.3M543.1M555.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income185.9M222.4M182.7M247.4M
 
 
 
 
 
Extraordinary Credit--0.000.001.2M
 
 
Extraordinary Charge---10.8M0.00-22.7M
 
 
 
Interest Expense On Debt11.6M10.2M9.2M6.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income175.3M203.1M176.1M221.3M
 
 
 
 
 
Income Taxes-109.8M-110.4M-96.4M-111.1M
 
 
 
 
 
Net Income65.4M92.7M79.7M110.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS98.7M100.4M100.8M101.5M
 
 
 
 
 
Shares To Calculate EPS Diluted112.2M113.0M117.4M114.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.58$0.82$0.70$0.96
 
 
 
 
 
EPS Diluted$0.58$0.82$0.70$0.96
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account